EarCentric EX2 vs Lexie B2 Plus

The EarCentric EX2 is a behind-the-ear prescription hearing aid priced at $218, positioning it as a budget-friendly option in the prescription category. In HearAdvisor's lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking #35 of 39 prescription hearing aids tested. This 2021 release demonstrates mixed performance across key metrics. Its standout strength is feedback handling, scoring an excellent 4.7/5—essentially matching the category average and indicating reliable stability during movement. However, speech performance is a significant weakness: speech in quiet scores just 1.0/5 (2.40 points below the category average of 3.40), and speech in noise scores 1.0/5 (1.11 points below average). These low absolute scores suggest limited audibility enhancement in our standardized test conditions. Own-voice comfort scores 2.3/5, which is mixed in absolute terms and 0.40 points below the category average. Music streaming scored 0.0/5, indicating this device is not suited for audio entertainment purposes. The EarCentric EX2 may appeal to budget-conscious consumers who prioritize cost over performance, but alternatives exist at similar or lower price points with stronger test results. The RxEars Rxi, available in the same price range, scored 4.07/5 in our testing. Consumers seeking entry-level amplification should weigh the significant speech clarity limitations against the low purchase price.

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5 in HearAdvisor's lab testing, ranking #7 among 65 OTC devices. Priced at $899, this behind-the-ear rechargeable device has earned back-to-back Expert's Choice Awards in 2023 and 2024. In our testing, the B2 Plus demonstrates strong speech-in-quiet performance at 4.3/5, which is 1.49 points above the OTC category average. Own-voice comfort is excellent at 4.8/5, measuring 2.29 points above average—a notable strength that may appeal to users who find their own voice bothersome with other devices. Speech-in-noise scores 2.1/5, which is above the category average by 0.58 points but remains mixed in absolute terms, reflecting the broader challenge OTC devices face in noisy environments. The device does show a weakness in feedback handling, scoring 2.8/5—which is 1.74 points below the category average of 4.54/5. Users may encounter occasional whistling during activities that bring objects close to the ear. Music streaming performance is mixed at 2.6/5, though still 0.68 points above the OTC average. The Lexie B2 Plus offers both iPhone and Android streaming compatibility. It's well-suited for users prioritizing clear speech in quieter settings and natural own-voice perception, though those frequently in noisy environments or concerned about feedback stability may want to consider alternatives like the Sony CRE-E10 in this price range.